Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitubercular Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableStudy completedNCT00096850
What this trial is testing

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00002192
What this trial is testing

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Anderson Clinical Research
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Large-scale testing (Phase 3)Looking for participantsNCT06253715
What this trial is testing

Shortened Regimen for Drug-susceptible TB in Children

Who this might be right for
TuberculosisTuberculosis, PulmonaryTuberculosis, Lymph Node+1 more
Johns Hopkins University 860
Testing effectiveness (Phase 2)Study completedNCT03959566
What this trial is testing

PanACEA Sutezolid Dose-finding and Combination Evaluation

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 75
Not applicableStudy completedNCT00963924
What this trial is testing

D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00685360
What this trial is testing

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug ResistantExtensively Drug-Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 481
Not applicableStudy completedNCT00000636
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,000
Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132